Cholinergic Neurotransmission - A Common Underlying Mechanism of Cognitive and Gait Impairment in Parkinson Disease
Latest Information Update: 20 Oct 2023
At a glance
- Drugs Rivastigmine (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
Most Recent Events
- 22 Oct 2021 Status changed from recruiting to completed.
- 02 May 2019 Planned End Date changed from 1 Mar 2021 to 1 Apr 2021.
- 02 May 2019 Planned primary completion date changed from 1 Mar 2021 to 1 Apr 2021.